SportsHero Limited (ASX:SHO)

Verve Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	0.05	0.03	0.14	1.76	1.38	0.15
Cash & Short-Term Investments	0.05	0.03	0.14	1.76	1.38	0.15
Cash Growth	-45.57%	-80.27%	-92.31%	27.91%	790.92%	210.54%
Accounts Receivable	0.01	0	0	-	-	-
Other Receivables	-	0	0.04	0	0	0.15
Receivables	0.01	0	0.04	0	0	0.15
Total Current Assets	0.06	0.03	0.18	1.76	1.38	0.3
Property, Plant & Equipment	0	0	0.03	0	0	0.02
Total Assets	0.07	0.03	0.2	1.77	1.38	0.32
Accounts Payable	0.2	0.13	0.21	0.1	0.07	0.22
Accrued Expenses	-	0.19	0.12	0.08	0.07	0.06
Short-Term Debt	0.18	0.27	0.33	-	-	0.21
Current Portion of Leases	-	-	0	-	-	0.02
Total Current Liabilities	0.37	0.6	0.67	0.18	0.14	0.5
Long-Term Leases	-	-	0.01	-	-	-
Total Liabilities	0.37	0.6	0.68	0.18	0.14	0.5
Common Stock	17.56	16.87	16.3	16.21	14.16	11.78
Retained Earnings	-17.71	-17.24	-16.74	-15.48	-13.77	-12.29
Comprehensive Income & Other	-0.16	-0.19	-0.04	0.86	0.85	0.32
Shareholders' Equity	-0.31	-0.56	-0.48	1.58	1.24	-0.18
Total Liabilities & Equity	0.07	0.03	0.2	1.77	1.38	0.32
Total Debt	0.18	0.27	0.35	-	-	0.22
Net Cash (Debt)	-0.12	-0.25	-0.21	1.76	1.38	-0.07
Net Cash Growth	-	-	-	27.91%	-	-
Net Cash Per Share	-0.00	-0.00	-0.00	0.00	0.00	-0.00
Filing Date Shares Outstanding	731.45	617.83	575	569.79	478.97	328.21
Total Common Shares Outstanding	731.45	617.83	575	569.79	478.97	328.21
Working Capital	-0.31	-0.56	-0.49	1.58	1.24	-0.2
Book Value Per Share	-0.00	-0.00	-0.00	0.00	0.00	-0.00
Tangible Book Value	-0.31	-0.56	-0.48	1.58	1.24	-0.18
Tangible Book Value Per Share	-0.00	-0.00	-0.00	0.00	0.00	-0.00
Machinery	-	0.02	0.02	0.01	0.01	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.